NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N.M. and MALVERN, Pa., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (“Avisa” ...
AVISA SNAPS UP ANOTHER FROM SIGNAL: Another executive from the Signal Group has joined Avisa, the European firm growing its U.S. presence. Noe Garcia, who was previously a managing director, will be a ...
SANTA FE, N.M., June 22, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for ...
Avisa Pharma, which is developing a breath test to detect respiratory diseases like pneumonia, COPD and tuberculosis, is raising a small debt round. The New Mexico upstart has raised $914,359 of a ...
PARIS, Oct. 2, 2019 /PRNewswire/ -- Avisa Partners, a global firm specialized in managing sensitive matters, today announced it has expanded beyond continental Europe and named Eric Bovim as CEO of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results